Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

DXR Relative to the S&P 500

DXR Relative to the Sector

Seasonal Chart Analysis

Analysis of the Daxor Corporation (NASD:DXR) seasonal charts above shows that a Buy Date of December 17 and a Sell Date of April 3 has resulted in a geometric average return of 7.37% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 16.41% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage and andrology services, such as semen analysis, sperm washing, and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in Oak Ridge, TN.

To download DXR seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: DXR